Cargando…
Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol
Lecithin:cholesterol acyltransferase (LCAT) and LCAT-activating compounds are being investigated as treatments for coronary heart disease (CHD) and familial LCAT deficiency (FLD). Herein we report the crystal structure of human LCAT in complex with a potent piperidinylpyrazolopyridine activator and...
Autores principales: | Manthei, Kelly A, Yang, Shyh-Ming, Baljinnyam, Bolormaa, Chang, Louise, Glukhova, Alisa, Yuan, Wenmin, Freeman, Lita A, Maloney, David J, Schwendeman, Anna, Remaley, Alan T, Jadhav, Ajit, Tesmer, John JG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277198/ https://www.ncbi.nlm.nih.gov/pubmed/30479275 http://dx.doi.org/10.7554/eLife.41604 |
Ejemplares similares
-
Structure and function of lysosomal phospholipase A2 and lecithin:cholesterol acyltransferase
por: Glukhova, Alisa, et al.
Publicado: (2015) -
Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles
por: Manthei, Kelly A., et al.
Publicado: (2020) -
Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings
por: Norum, Kaare R., et al.
Publicado: (2020) -
Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides
por: Casteleijn, Marco G., et al.
Publicado: (2018) -
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency
por: Vitali, Cecilia, et al.
Publicado: (2022)